21 januari: Virtual Trials

Question 1

Name challenges related to Virtual Trials. (5)

Answer 1

1) Are we currently having a lack of data? Do we want more data? The researchers might collect data that is not relevant to the main research questions.
2) data protection / privacy concerns
3) policy not yet in place
4) no best practices / no clear definition on virtual trials
5) old people and technology

Question 2

Name opportunities related to Virtual Trials. (3)

Answer 2

1) pressure from society and FDA to include more diverse patient population (e.g. hard to reach patients)
2) faster data processing (in real time)
3) less invasive

Question 3

What is, according to Eric, the ultimate form of Virtual Trials?

Answer 3

A hybrid form, where you go to the Investigational site to take your medicine, and where you can answer any CT-related questions at home.

Question 4

Which shareholders benefit the most from Virtual Trials?

Answer 4

patients, they can remain in their own home aka safe environment